Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lipid-lowering Therapy in Patients With High Cardiovascular Risk and Their 3-year Mortality Rate in General Practice in Thailand

NCT00684151 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00684151 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lipid-lowering Therapy in Patients With High Cardiovascular Risk and Their 3-year Mortality Rate in General Practice in Thailand
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
April 30, 2008
Completion date
November 30, 2011
Enrollment
1,240 (actual)
Sites
49

Conditions

As the registry lists them; a condition with its own page is linked.

dyslipidemia